x4pharma.com - XFOR Net Assets per Single Share

Graphic logo of X4 Pharmaceuticals (XFOR)

Revenue growth at X4 Pharmaceuticals (XFOR) is being driven by the rapid commercial launch of its first approved drug. Massive R&D expenditures are being offset by the scalability of Xolremdi capsule production. The book value per share clearly demonstrates the actual volume of net assets, with 1.63 serving as the current metric level. A monopoly position in the therapy of rare pathologies allows the company to exercise pricing power over treatment costs.

X4 Pharmaceuticals Inc. (XFOR): Share Book Value from 07/04/2022 to 10/27/2026

x4pharma.com - analytical breakdowns and key metrics (XFOR)

- price and consensus price forecast:
Price Chart X4 Pharma|XFOR - Average Forecast Price
- market capitalization data:
Market Value X4 Pharmaceuticals, Inc.|XFOR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share X4 Pharmaceuticals|XFOR - Net Asset Value|Market Capitalization to Book Value Ratio x4pharma.com|XFOR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital X4 Pharmaceuticals|XFOR - Long-Term Debt to Capital|Short-Term Debt to Equity X4 Pharmaceuticals, Inc.|XFOR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio X4 Pharmaceuticals, Inc.
Fundamental company valuation:X4 Pharma - XFOR
Manufactured products of X4 Pharmaceuticals, Inc.

Book value per share separates the fundamental asset backing of X4 Pharmaceuticals (XFOR) from speculative expectations by measuring the portion of net equity per share after deducting all liabilities. The trend in book value per share confirms the company's transition toward operational self-sufficiency driven by orphan drug sales, which transforms the asset structure and strengthens the overall financial stability of the business.

Competitors of X4 Pharmaceuticals (XFOR)

ARGX (Argenx) - Net Assets per Single Share|BNTX: Net Asset Value per Share|Net Assets per Single Share Abivax Corp ABVX|ADMA (admabiologics.com) - Accounting Value of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Astria Pharma (ATXS) - Accounting Value per Share|ENGN (enGene Corp) - Equity per Share|RAPT (RAPT Therapeutics, Inc.) - Equity per Share|Aerovate Therapeutics - Accounting Value per Share|Accounting Value of a Share Aclaris Therapeutics, Inc.|Kyverna Therapeutics Inc. - Net Assets per Single Share|Share Book Value TLSA|CABA (Cabaletta Bio Inc) - Book Value per Share|Accounting Value of a Share VTYX (Ventyx Biosciences)|Book Value per Share theratech.com THTX|AVTX - Book Value per Share|Net Assets per Single Share ELDN (Eledon Pharmaceuticals Inc.)|Agenus Inc (AGEN) - Accounting Value of a Share|Net Assets per Single Share Climb Bio, Inc|ZURA (Zura Bio Limited) - Accounting Value per Share|Book Value per Share atyrpharma.com|Book Value per Share ADAG|Book Value per Share ikenaoncology.com IMA|Accounting Value per Share STTK (Shattuck Labs)|Equillium Inc (EQ) - Book Value per Share|CNTB: Net Asset Value per Share|IMUX - Accounting Value per Share|ATRA (atarabio.com) - Book Value per Share|IFRX: Accounting Value per Share|ACET (Adicet Bio Inc.) - Book Price of a Share|Celularity Corp (CELU) - Book Value per Share|Net Assets per Share INMB|Book Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR (Kezar Life Sciences, Inc.)|Book Value per Share SAB Biotherapeutics Inc. SABS|AKTX - Book Value per Share|ENLV: Net Assets per Single Share|q32bio.com (QTTB) - Net Assets per Single Share|GOVX - Net Assets per Single Share|Net Assets per Share EDSA|Accounting Value per Share IBIO (iBio Inc)|Equity per Share CARM|XTLB: Book Value per Share|Share Book Value Bolt Biotherapeutics, Inc. BOLT|HCW Biologics, Inc. (HCWB) - Net Assets per Single Share|APVO - Net Asset Value per Share|Net Assets per Single Share AIM (AIM ImmunoTech, Inc.)|aditxt.com (ADTX) - Accounting Value of a Share|Net Assets per Single Share GRI (GRI Bio Corporation)|XRTX (XORTX Therapeutics Inc.) - Share Book Value|HIND: Book Value per Share|Accounting Value of a Share REVB|Book Value per Share Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai SCNI|Net Assets per Single Share CALI|AFMD - Accounting Value of a Share|Allakos Inc. (ALLK) - Net Assets per Single Share|HOOK: Accounting Value per Share|IGM Biosciences (IGMS) - Book Value per Share|Book Value per Share ITOS|OCEA: Accounting Value per Share|Accounting Value of a Share TCBP|Book Value per Share thirdharmonicbio.com